Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiotech Gwth Regulatory News (BIOG)

Share Price Information for Biotech Gwth (BIOG)

Share Price is delayed by 15 minutes
Get Live Data
1,232.00    -30.00 (-2.38%)
Bid:
1,232.00
Ask:
1,246.00
Spread: 14.00 (1.136%)
Market Cap: £239.12m
BIOG Live PriceLast checked at - London Stock Exchange

Intraday Biotech Gwth Share Chart

Holding(s) in Company

7 May 2025 13:36

The Biotech Growth Trust PLC - Holding(s) in Company

The Biotech Growth Trust PLC - Holding(s) in Company

PR Newswire

LONDON, United Kingdom, May 07

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0000385517

Issuer Name

THE BIOTECH GROWTH TRUST PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

 City of Bradford - West Yorkshire Pension Fund

City of registered office (if applicable)

BRADFORD

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

02-Mary-2025

6. Date on which Issuer notified

07-May-2025

7. Total positions of person(s) subject to the notification obligation

.

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.020000

0.000000

4.020000

1070689

Position of previous notification (if applicable)

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0000385517

 

1070689

 

4.020000

Sub Total 8.A

1070689

4.020000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

 

 

Sub Total 8.B1

 

 

 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

Sub Total 8.B2

 

 

 

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

07-May-2025

13. Place Of Completion

BRADFORD



Date   Source Headline
10th Apr 20265:23 pmPRNTransaction in Own Shares
10th Apr 20262:36 pmPRNNet Asset Value(s)
9th Apr 20261:22 pmPRNNet Asset Value(s)
8th Apr 20263:05 pmPRNNet Asset Value(s)
7th Apr 20261:08 pmPRNNet Asset Value(s)
2nd Apr 20265:01 pmPRNTransaction in Own Shares
2nd Apr 20262:23 pmPRNNet Asset Value(s)
1st Apr 20264:16 pmPRNNet Asset Value(s)
1st Apr 20269:59 amPRNTotal Voting Rights
1st Apr 20267:00 amPRNBiogen, Inc. to acquire BIOG portfolio company, Apellis Pharmaceuticals, Inc.
31st Mar 202612:42 pmPRNNet Asset Value(s)
30th Mar 202612:43 pmPRNNet Asset Value(s)
27th Mar 20265:16 pmPRNTransaction in Own Shares
27th Mar 20261:35 pmPRNNet Asset Value(s)
26th Mar 20261:08 pmPRNNet Asset Value(s)
25th Mar 20262:08 pmPRNNet Asset Value(s)
24th Mar 202612:34 pmPRNNet Asset Value(s)
23rd Mar 20263:13 pmPRNNet Asset Value(s)
20th Mar 20265:18 pmPRNTransaction in Own Shares
20th Mar 20261:55 pmPRNNet Asset Value(s)
19th Mar 202612:38 pmPRNNet Asset Value(s)
18th Mar 20261:35 pmPRNNet Asset Value(s)
17th Mar 202612:41 pmPRNNet Asset Value(s)
16th Mar 20262:15 pmPRNNet Asset Value(s)
13th Mar 20265:19 pmRNSTransaction in Own Shares
13th Mar 20265:19 pmPRNTransaction in Own Shares
13th Mar 20262:54 pmPRNNet Asset Value(s)
12th Mar 20261:16 pmPRNNet Asset Value(s)
12th Mar 20267:00 amRNS-RKepler Trust Intelligence: New Research
11th Mar 20262:08 pmRNSMonthly Fact Sheet as at 28 February 2026
11th Mar 20262:08 pmPRNMonthly Fact Sheet as at 28 February 2026
11th Mar 20261:00 pmPRNNet Asset Value(s)
10th Mar 20261:28 pmPRNNet Asset Value(s)
9th Mar 20261:49 pmPRNNet Asset Value(s)
6th Mar 20265:12 pmPRNTransaction in Own Shares
6th Mar 20261:21 pmPRNNet Asset Value(s)
5th Mar 202612:16 pmPRNNet Asset Value(s)
4th Mar 20261:17 pmPRNNet Asset Value(s)
3rd Mar 20261:01 pmPRNNet Asset Value(s)
2nd Mar 20261:17 pmPRNNet Asset Value(s)
2nd Mar 202610:11 amPRNTotal Voting Rights
2nd Mar 20267:00 amPRNInvestor Webinar
27th Feb 20265:43 pmPRNTransaction in Own Shares
27th Feb 20262:10 pmPRNNet Asset Value(s)
26th Feb 20261:58 pmPRNNet Asset Value(s)
25th Feb 20262:31 pmPRNNet Asset Value(s)
24th Feb 202612:23 pmPRNNet Asset Value(s)
23rd Feb 20261:45 pmPRNNet Asset Value(s)
20th Feb 20265:21 pmPRNTransaction in Own Shares
20th Feb 20261:35 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.